Coromandel International stock (INE024A01027): Net profit plunges 76% in Q4

Coromandel International's consolidated net profit fell 75.86% to Rs 139.93 crore in the March 2026 quarter from Rs 579.67 crore a year earlier, despite 26% income growth driven by subsidies.

Coromandel International, a leading Indian agritech firm, reported a sharp 75.86% decline in consolidated net profit to Rs 139.93 crore for the quarter ended March 2026, down from Rs 579.67 crore in the year-ago period, according to Tickertape as of 11th May 2026. Total income grew 26% amid subsidy support, highlighting resilience in a tough market. The stock traded at ?1891.70 on May 11, 2026, reflecting a 4.10% drop over the past week.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Coromandel International Ltd
• Sector/industry: Agritech / Fertilizers & Phosphates
• Headquarters/country: India
• Core markets: India, with exports
• Key revenue drivers: Phosphatic fertilizers, crop protection, specialty nutrients
• Home exchange/listing venue: NSE/BSE (COROMANDEL)
• Trading currency: INR

Coromandel International: core business model

Coromandel International operates as a major player in India's fertilizer and agritech sector, focusing on phosphatic fertilizers, crop protection products, and specialty nutrients. The company produces a range of products including single super phosphate (SSP), NPK complexes, and pesticides, serving farmers across India. Its integrated model spans manufacturing, marketing, and distribution, with key facilities in Andhra Pradesh and other states.

Established as part of the Murugappa Group, Coromandel emphasizes sustainable agriculture through bio-products and precision farming solutions. Revenue is primarily from domestic sales, with growing exports to Asia and Africa. The firm's subsidy-dependent phosphatic segment remains central, exposing it to government policy shifts.

Main revenue and product drivers for Coromandel International

Phosphatic fertilizers account for over 70% of revenue, bolstered by nutrient-based subsidy (NBS) schemes that drove 26% income growth in Q4 FY26 despite profit pressures, per recent reports. Crop protection chemicals contribute around 20%, with new launches in insecticides and fungicides targeting high-value crops like rice and cotton.

Specialty nutrients and bio-products are emerging drivers, aiming for 15-20% of mix by 2030. Key brands like Gromor and Godavari deliver farm-level solutions. For US investors, Coromandel offers exposure to India's $50B+ fertilizer market, indirectly linked to global commodity cycles affecting US agribusiness.

Industry trends and competitive position

India's fertilizer sector faces raw material volatility, with phosphate prices easing in 2026 but subsidy reforms looming. Coromandel holds a top-5 position in phosphatics, competing with IFFCO and Mosaic India. Its backward integration into rock phosphate mining enhances margins versus import-reliant peers.

ESG trends favor Coromandel's water-efficient plants and organic product push, aligning with global sustainability demands. The sector's 8-10% CAGR supports growth, though policy risks persist.

Why Coromandel International matters for US investors

Listed on NSE/BSE, Coromandel provides US investors access to India's booming agriculture economy via ADRs or direct trading on global platforms. Its ties to global phosphate supply chains link it to US firms like Mosaic, offering diversification amid US farm input inflation.

With India's food security focus, Coromandel benefits from rising demand, relevant for portfolios eyeing emerging market agrotech plays.

Conclusion

Coromandel International's Q4 FY26 results show robust top-line growth from subsidies offsetting a steep profit drop, underscoring sector challenges. With a strong market position and diversification efforts, the company navigates policy and commodity headwinds. Investors track upcoming subsidy policies and monsoon outlook for cues.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.